Method of treating or preventing autoimmune uveoretinitis in mammals
US5961977A · kind A · utility
6Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 10, 1995 |
| Grant date | Oct 5, 1999 |
| Priority date | — |
| Expiry date | Apr 10, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/543
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating or preventing the clinical manifestation of an autoimmune disease having the symptoms of uveoretinitis in a mammal in need of such treatment comprising orally administering to said mammal an effective amount of an autoantigen, e.g., S antigen (S-Ag), and/or biologically active fragments, or analogs thereof specific for uveoretinitis. Also provided is a pharmaceutical formulation useful for treating or preventing uveoretinitis in mammals comprising an effective amount of one or more of the foregoing autoantigen, fragments or analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.